Canada Markets close in 3 hrs 54 mins

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
62.95+0.61 (+0.98%)
As of 12:06PM EDT. Market open.

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Sept. 30.

Sign in to post a message.
  • L
    L
    Did my monthly check of this board. Sharbe and Sal are nowhere to be found, have they finally sold? :D
  • m
    mignella
    It’s a great way to pick out potential trades for the day.I heard about GILD the other day on (http://dailygainalerts.tech). It’s looking like an interesting play.
  • K
    Kjinman
    Repost from an Entrepreneur article on GILD's current valuation...

    In terms of forward non-GAAP P/E, GILD is trading at 9.62x, 47.2% lower than the industry average which is 18.24x.

    GILD forward EV/EBITDA of 7.50x is 43.1% lower than industry average of 13.18x.

    It's forward EV/EBIT of 8.68x is 47.4% lower than the industry average of 16.49x.

    My opinion, GILD is far from average and should be trading around $120 a share with buyouts at $140 plus.
  • B
    Bunny
    I like the tug in acquisition. It shows that GILD ability to grow because of its power to continuously generating great free cash flow.
  • S
    Steve G
    GILD's 50-day exponential moving average just crossed over the 200-day exponential moving average for the first time since February 2022.

    It would not take much a spark now to cause a bit of a bullish run. I would watch the newswires carefully over the next week because any favorable development for Gilead is likely to be met by a fairly positive reaction in the stock.
  • j
    jrward
    Gild will report after hours Thursday 10/27! They will beat the streets estimates with impressive updates in their pipelines!! Oday is doing exactly what he was hired to do turn this monster one trick pony into a more diversified entity which is happening!! If you own it cheer on the game plan or sell it.
  • W
    Warbaby
    HIV back in play as Gilead's patent expired drugs go back on patent protection until 2031. Pipeline growth restablished!
  • S
    Steven
    64.85-0.75 (-1.14%)
    As of 12:27PM EDT. Market open. Funny that's just about the amount of dividend.
  • K
    Kjinman
    I made a post last week and it was oddly erased, so I will post it again. DJT took REGN antibodies and GILD Remdesivir; I jokingly said that these two companies were already linked and 'a DJT divided amongst itself cannot stand'.

    REGN only has to print a measly 250M shares to purchase all of GILD at an exchange of .2 shares REGN for every 1 share of GILD. That would equate to a purchase price of $145 a share. After the newly issued shares, REGN will have an outstanding share count of 350M. They should then split the shares 10 for 1 bringing share count to 3.5B. The REGN investment of 180B to buy GILD will recoup in max 10 years given GILD should soon be heading towards 18B a year in net income.

    Powerhouse deal! Let's print it boys!
  • N
    NYSE
    $80 stock selling for $68 & change
  • F
    Frank B
    We will fly when we sell as long as we are a stakeholder company the street will not take us seriously
  • F
    Frank B
    Kite just approved in Europe. Yes
  • N
    NYSE
    $80 stock selling for $65.35. Recent news has never been so good. Let's pump it higher.
  • F
    First
    Ex dividend date is September 14th, this Wednesday for 4.5%.
  • N
    NYSE
    We've reached average daily volume in 40 minutes.
  • s
    simon
    Gild MDGL resmetirom. FDA approval for NASH is coming any day
  • R
    R.G.
    Isn't It Strange
    that all of a sudden Sharpe and others have gotten off O'Days back?
  • T
    Tuan
    So with all these excited news Gilead jumped up to 68s and next day back to 65-66. That is it. I have said Gilead could not jump until their sells verified. That will be almost 3 months away. If Trodelvy sell does not reach 250 mil per quarter, Gilead does not go pass $70. I think at least gona need 2 quarters, 2nd of 2023.
  • S
    Sharbe
    I will say, with all the good news recently, that if O'Day wasn't CEO, this stock would be trading at $100. No one wants to own a stock where that guy is CEO. He gets rich and everyone else suffers!
  • a
    ackmann
    I am so tired of GILD doing nothing all day. Can you move??? I have been reading (http://Achieverspot.tech) for a month now and the stocks there actually go!